Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study
Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study
Authors of this article:
Eva Clemens1, 2
;
Annelot JM Meijer1
;
Linda Broer3
;
Thorsten Langer4
;
Anne-Lotte LF van der Kooi1, 2, 5
;
André G Uitterlinden3
;
Andrica de Vries1, 2
;
Claudia E Kuehni6, 7
;
Maria L Garrè8
;
Tomas Kepak9, 10
;
Jarmila Kruseova11
;
Jeanette F Winther12, 13
;
Leontien C Kremer1, 14
;
Eline van Dulmen-den Broeder1, 15
;
Wim JE Tissing1, 16
;
Catherine Rechnitzer17
;
Line Kenborg12
;
Henrik Hasle18
;
Desiree Grabow19
;
Ross Parfitt20
;
Harald Binder19, 21
;
Bruce C Carleton22
;
Julianne Byrne23
;
Peter Kaatsch19
;
Antoinette am Zehnhoff-Dinnesen20
;
Oliver Zolk24
;
Marry M van den Heuvel-Eibrink1
There are currently no tweets available for this article within the specified range.